· 001 · AI News · 5 min read
Anthropic's $19B Deal, OpenAI's Sovereign Wealth Proposal, Zuckerberg on AI Agents — AI News Briefing
Top 7 Stories
1. Anthropic Signs Record $19 Billion Lease for AI Infrastructure Campus
Anthropic has inked a staggering $19 billion lease agreement with TeraWulf for a massive AI-infrastructure campus, marking one of the largest real estate deals in the AI sector’s history. The campus will be purpose-built to support Anthropic’s growing compute needs as it competes with OpenAI and Google in the frontier-model race. In a parallel move, Anthropic is also reportedly in discussions with Samsung to design a custom AI chip, signaling the company’s ambition to vertically integrate its hardware stack and reduce reliance on NVIDIA.
2. OpenAI Proposes Giving 5% Equity to a US Sovereign Wealth Fund
OpenAI has floated a proposal to donate 5% of its equity to a US sovereign wealth fund — an extraordinary overture to the Trump administration as the company navigates an increasingly complex regulatory landscape. The proposal, first reported by TechCrunch, would effectively give the government a direct financial stake in the AI boom. It arrives alongside reports that OpenAI has been lobbying to secure government partnership on AI infrastructure, raising questions about the blurring lines between private AI labs and federal interests.
3. Zuckerberg Tells Staff AI Agents Haven’t Progressed Fast Enough
In a rare moment of candor, Mark Zuckerberg told Meta employees that AI agents have not progressed as quickly as he had hoped, according to an internal memo obtained by TechCrunch. The admission is notable given Meta’s aggressive push into agentic AI across WhatsApp, Messenger, and its enterprise tools. Zuckerberg reportedly urged teams to accelerate development, suggesting that the agent revolution — widely predicted to define 2026 — may be hitting real-world friction that even the largest labs are struggling to overcome.
4. Microsoft Launches AI Deployment Company with $2.5 Billion Commitment
Microsoft has launched a dedicated AI deployment company, backed by an initial $2.5 billion commitment, to help enterprise customers integrate and operationalize AI systems at scale. The move positions Microsoft to capture more of the AI implementation market beyond cloud infrastructure, offering end-to-end services from model selection to production deployment. It’s the latest escalation in the hyperscaler AI wars, pitting Microsoft’s new unit against existing partners and competitors alike.
5. Anthropic Sets Its Sights on Drug Discovery with Claude Science
Anthropic is expanding beyond language models into biotechnology: the company wants to develop its own drugs using AI. Dubbed “Claude Science,” the initiative aims to apply Anthropic’s models to drug discovery and biomedical research, putting the company in direct competition with AI-native biotech firms like Recursion and Insilico Medicine. The pivot signals that frontier AI labs increasingly see life sciences — not just chatbots — as the ultimate proving ground for their technology.
6. Illinois Governor Signs Nation-Leading AI Safety Law
Illinois Governor JB Pritzker signed what is being called the most comprehensive state-level AI safety law in the United States. The legislation imposes transparency requirements on AI developers, mandates risk assessments for high-stakes AI applications, and establishes an AI oversight body. The law is expected to serve as a template for other states — and potentially federal legislation — as Washington continues to debate AI governance.
7. Midjourney Demands Hollywood Studios Disclose Their AI Usage
Midjourney is turning the tables on Hollywood: the AI image-generation company wants major studios to publicly reveal the details of their own AI usage in film and television production. The demand, framed as a transparency initiative, comes as Hollywood grapples with the rise of AI actors (including Tilly Norwood, the first AI-generated actor to land a lead movie role) and AI-assisted VFX. Midjourney’s push highlights the growing tension between traditional creative industries and AI-native companies over disclosure standards and creative credit.
Trend Watch
| Story | Impact | Why It Matters |
|---|---|---|
| AI Infrastructure Arms Race | Anthropic’s $19B lease + Microsoft’s $2.5B deployment company = unprecedented capital flows | The winners of the AI era are being decided by who controls the physical compute, not just the algorithms. |
| AI Agents Hit a Wall | Zuckerberg’s candid admission that agents are behind schedule | If Meta — with its billions of users and vast resources — can’t crack agents, the entire agent-first thesis for 2026 needs a rethink. |
| AI Safety Goes Mainstream | Illinois passes nation-leading AI law; Cloudflare demands AI companies pay for publisher content | The regulatory and commercial frameworks around AI are hardening from voluntary pledges into enforceable law and contract. |
| AI Meets Biotech | Anthropic’s Claude Science targets drug discovery | Frontier AI labs are betting that their models’ real value lies in scientific breakthroughs, not just chat interfaces. |
| Hollywood’s AI Reckoning | Midjourney demands studio transparency; first AI actor lands lead role | The creative industry’s uneasy relationship with AI is escalating from debate to structural change. |
What to Watch
- Anthropic-Samsung chip talks: If Anthropic moves forward with a custom chip, it could reshape the AI hardware landscape and challenge NVIDIA’s dominance. Expect more details in the coming weeks.
- OpenAI’s equity proposal fallout: The 5% sovereign wealth fund offer is unprecedented. Watch for reaction from lawmakers and rival AI companies — this could become a major policy flashpoint.
- Agent acceleration at Meta: After Zuckerberg’s internal memo, expect Meta to ship agent features at a faster clip. Llama 4 and its agentic capabilities will be the bellwether.
- Federal AI legislation: Illinois’s law may catalyze stalled federal AI bills. With the 2026 midterms approaching, AI safety could become a rare bipartisan priority.
- AI in pharma earnings: As Anthropic and others push into drug discovery, Q2 earnings from AI-biotech firms will reveal whether the AI-in-drugs thesis is translating into pipeline progress.